Correlating Medication Intake with PAP Therapy Outcomes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The interaction between medications and positive airway pressure (PAP) therapy for sleep-disordered breathing (SDB) is not well understood, leading to potential adverse effects when prescribing medications, especially with drug-drug interactions and non-adherence to prescriptions, posing risks to patient safety.

Innovation Solution

A processing system that correlates medication intake and SDB therapy information to identify interactions, determining if the correlation exceeds a threshold, and recommending adjustments to medication or PAP therapy to improve outcomes and reduce side effects, with the ability to monitor and adjust in real-time.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If clinicians prescribe medication to subjects undergoing PAP therapy, then therapeutic benefits may be achieved, but adverse effects and safety risks increase due to unknown drug-drug interactions

Engineering Contradiction:
Improvetherapeutic benefitVSAvoidadverse effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system continuously collects medication intake data and PAP therapy outcome data, processes this information to determine correlation data, and provides feedback to clinicians about potential adverse interactions. This closed-loop feedback mechanism enables clinicians to adjust prescriptions based on actual observed correlations between medications and therapy outcomes, thereby maintaining therapeutic benefits while minimizing adverse effects.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The processing system acts as an intermediary between medication prescription and therapy outcome. It collects data from multiple sources (medication information, therapy information), processes this data to determine correlations, and provides recommended actions. This intermediary system bridges the gap between prescription and outcome by introducing an analysis layer that identifies potential adverse interactions before they manifest as harmful effects.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If clinicians prescribe PAP therapy to subjects already taking medication, then sleep disordered breathing treatment is provided, but safety risks increase due to potential interactions with existing medications

Engineering Contradiction:
Improvetherapy effectivenessVSAvoidsafety risks
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system performs preliminary analysis by collecting and processing medication information and therapy information before adverse effects can occur. It determines correlation data and provides recommended actions in advance, allowing clinicians to adjust prescriptions or therapy parameters proactively rather than reactively, thereby maintaining therapy effectiveness while preventing safety risks.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system establishes a feedback loop that continuously monitors the relationship between medication intake and PAP therapy outcomes. By processing correlation data and providing recommended actions, it enables clinicians to make informed decisions about therapy prescription, thereby maintaining effectiveness while mitigating safety risks associated with potential drug interactions.

Inventive Principle:
Principle #23Feedback

3Adaptability or versatility

If subjects take multiple medications including over-the-counter drugs, then comprehensive treatment of comorbidities is achieved, but prediction of adverse effects becomes difficult due to non-adherence and drug-drug interactions

Engineering Contradiction:
Improvecomprehensive treatmentVSAvoidadverse effect prediction
Core Design Contradiction:
Adaptability or versatilityVSDifficulty of detecting and measuring

Solution Approach 1:

The system is designed to handle multiple types of medications (prescribed and over-the-counter) and multiple data sources universally. It collects medication information, therapy information, and correlation data in a unified manner, processing all this information to provide comprehensive recommended actions. This multi-functional approach enables the system to manage complex polypharmacy scenarios while maintaining the ability to detect and measure adverse effects.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system establishes continuous feedback loops that monitor actual medication intake and therapy outcomes. By processing correlation data from multiple sources and providing recommended actions, it transforms the complexity of polypharmacy into actionable insights, enabling detection and measurement of adverse effects that would otherwise be difficult to predict due to non-adherence and drug-drug interactions.

Inventive Principle:
Principle #23Feedback

4Adaptability or versatility

If correlation analysis is performed on medication and therapy data, then personalized recommendations can be provided, but system complexity increases due to data processing requirements

Engineering Contradiction:
Improvepersonalized recommendationsVSAvoiddata processing system
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The system uses feedback mechanisms to manage complexity by processing data iteratively. It collects medication and therapy information, determines correlation data, provides recommended actions, and continues monitoring. This feedback-driven approach allows the system to provide personalized recommendations without requiring all complexity to be resolved upfront, instead managing complexity through continuous adaptive processing.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The processing system performs self-service by automatically collecting, processing, and analyzing data without requiring manual intervention for each analysis. It autonomously determines correlation data and generates recommended actions, thereby reducing the operational complexity burden on users while maintaining the capability to provide personalized recommendations.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS20240424237A1System and method for determining a correlation between medication intake and sleep disordered breathing therapy outcome
Publication Date: 2024.12.26 KONINKLIJKE PHILIPS NV
  • US20240424237A1 patent drawing
  • US20240424237A1 patent drawing

AI summary

A system and method for determining a correlation between medication intake and sleep disordered breathing, SDB, therapy outcome for a subject taking at least one type of medication and being provided with SDB therapy. The SDB therapy comprises at least positive airway pressure, PAP, therapy provided by a PAP device. Medication information, relating to a medication intake of the subject, and SDB therapy information, relating to a therapy outcome of the SDB therapy, are obtained and correlated.